Israel, New Zealand each give tentative approval for sale of nasal spray to help stop COVID spread
The spray is a product from Biotech firm SaNOtize.
Israel and New Zealand have each given tentative approval for the sale of a nasal spray which may help in reducing the spread of COVID-19.
Biotech firm SaNOtize announced Monday the countries gave interim approval to sell its Nitric Oxide Nasal Spray or NONS, after clinical trials showed the spray was effective at preventing transmission, reducing symptoms and damage, and shortening the course of COVID-19, according to Reuters.
The inventor of the spray, Dr. Gilly Regev, told the Times of Israel that the spray could save millions of lives for people who are still waiting to get the vaccine.
Regev said that spray was ready for approval a year ago.
News, not Noise
- White House tells agencies to begin preparing for potential government shutdown
- DeSantis sidesteps Biden rationing, acquires new monoclonal antibodies from U.K. drug firm
- Effort to spread discredited Russia collusion theory welcomed by McCain Senate panel, memos show
- CDC alerts medical professionals about potential infectious diseases spread by Afghan evacuees
- Ten questions the Arizona election audit could answer Friday